BACKGROUND: This study examined the relationship of medication adherence to frequency of pulmonary exacerbation and rate of decline in FEV(1)% predicted (FEV(1)). METHODS: 95 CF patients aged 6 years or older and prescribed a pulmonary medication, were enrolled in a longitudinal retrospective review of medication adherence and health outcomes (the occurrence and frequency of intravenous (IV) antibiotic treatments and FEV(1)) over 12-months. Pharmacy refill records were used to calculate a medication possession ratio (MPR). RESULTS: Composite MPR predicted the occurrence of at least one pulmonary exacerbation requiring a course of IV antibiotics (IRR=2.34, p=0.05), but not the frequency of exacerbations, after controlling for gender, baseline FEV(1,) and regimen complexity. Composite MPR predicted baseline FEV(1) (estimate=29.81, p=.007), but not decline in FEV(1). CONCLUSIONS: These results demonstrate a significant relation between medication adherence and IV antibiotics in CF patients, highlighting the importance of addressing adherence during clinic visits to improve health outcomes.
BACKGROUND: This study examined the relationship of medication adherence to frequency of pulmonary exacerbation and rate of decline in FEV(1)% predicted (FEV(1)). METHODS: 95 CFpatients aged 6 years or older and prescribed a pulmonary medication, were enrolled in a longitudinal retrospective review of medication adherence and health outcomes (the occurrence and frequency of intravenous (IV) antibiotic treatments and FEV(1)) over 12-months. Pharmacy refill records were used to calculate a medication possession ratio (MPR). RESULTS: Composite MPR predicted the occurrence of at least one pulmonary exacerbation requiring a course of IV antibiotics (IRR=2.34, p=0.05), but not the frequency of exacerbations, after controlling for gender, baseline FEV(1,) and regimen complexity. Composite MPR predicted baseline FEV(1) (estimate=29.81, p=.007), but not decline in FEV(1). CONCLUSIONS: These results demonstrate a significant relation between medication adherence and IV antibiotics in CFpatients, highlighting the importance of addressing adherence during clinic visits to improve health outcomes.
Authors: Lisa Saiman; Nicole Mayer-Hamblett; Preston Campbell; Bruce C Marshall Journal: Am J Respir Crit Care Med Date: 2005-07-22 Impact factor: 21.405
Authors: B W Ramsey; M S Pepe; J M Quan; K L Otto; A B Montgomery; J Williams-Warren; M Vasiljev-K; D Borowitz; C M Bowman; B C Marshall; S Marshall; A L Smith Journal: N Engl J Med Date: 1999-01-07 Impact factor: 91.245
Authors: H J Fuchs; D S Borowitz; D H Christiansen; E M Morris; M L Nash; B W Ramsey; B J Rosenstein; A L Smith; M E Wohl Journal: N Engl J Med Date: 1994-09-08 Impact factor: 91.245
Authors: Lisa B Feng; Scott D Grosse; Ridgely Fisk Green; Aliza K Fink; Gregory S Sawicki Journal: Health Aff (Millwood) Date: 2018-05 Impact factor: 6.301
Authors: Gabriela R Oates; Irena Stepanikova; Steven M Rowe; Stephanie Gamble; Hector H Gutierrez; William T Harris Journal: Respir Care Date: 2018-12-11 Impact factor: 2.258
Authors: Michelle Sharp; Taylor Brown; Edward S Chen; Cynthia S Rand; David R Moller; Michelle N Eakin Journal: Chest Date: 2020-02-04 Impact factor: 9.410
Authors: Gregory S Sawicki; Clement L Ren; Michael W Konstan; Stefanie J Millar; David J Pasta; Alexandra L Quittner Journal: J Cyst Fibros Date: 2013-01-24 Impact factor: 5.482